Carico, Christine <br/><br/>
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.  [electronic resource] 

 -  PloS one  2012 
 - e33684 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0033684  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Dacarbazine--analogs & derivatives<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>PTEN Phosphohydrolase--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Prognosis<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Retrospective Studies<br/>Signal Transduction<br/>Survival Analysis<br/>Temozolomide<br/>Young Adult